The Single-use Bioprocessing Systems Market, estimated at USD 35.31 Bn in 2025, is expected to exhibit a CAGR of 17% and reach USD 105.97 Bn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
Single-use bioprocessing systems are disposable technologies used in bioprocessing, which include disposable bioreactors, mixers, bags, tubing, connectors, sensors, and sampling systems. These systems find major application in the production of biologics, including monoclonal antibodies, hormones, vaccines, and gene therapy.
Global Single-use Bioprocessing Systems Market- Drivers
One of the major drivers for the growth of the global single-use bioprocessing systems market is the growing demand for cost-effective and flexible bioprocessing systems from biopharmaceutical manufacturers. Single-use bioprocessing systems offer significant cost savings over traditional stainless steel-based systems as they eliminate the need for cleaning and sterilization of equipment between batches. This reduces operational costs and time required for changeovers between product batches. Additionally, single-use bioprocessing systems are highly flexible, as they can be assembled quickly according to the production need and then disposed of after single use. This flexibility helps biomanufacturers to adapt production needs rapidly based on changing market demands. They no longer need to make large capital investments in fixed stainless steel-based production equipment or be constrained by their production capacity. The flexibility and reduced costs provided by single-use bioprocessing systems are highly appealing to biopharma companies, driving increased adoption. The use of single-use technologies allows for quicker production turnarounds, as manufacturers can easily switch between product pipelines within the same manufacturing facility. This helps accelerate drug development timelines and bring products to market faster. For instance, according to the UN Department of Economic and Social Affairs report (2025) monoclonal antibody therapies for cancer and immunological diseases doubled from 6 in 2011 to 12 in 2025. The pandemic has also underscored the need for resilient supply chains. Single-use technologies gave biopharma plants the agility to reconfigure production and redirect resources towards Covid vaccines and therapeutics.
Global Single-use Bioprocessing Systems Market - Restraints
One challenge restraining the growth of the market is the limited and difficult-to-find supply of trained personnel with expertise in single-use bioprocessing systems. While the systems offer several advantages, their design, assembly, operation, and validation processes differ from traditional stainless steel systems. This requires specialized training and skills that are not widely available yet. The novel nature of these systems and the different assembly procedures mean that there is a lack of experienced and trained professionals in the industry currently. This skills gap is making it difficult for some biopharma companies to smoothly implement single-use technologies at scale. It is also increasing their costs of procuring third-party experts until in-house talent pools can be sufficiently developed through training programs.
Global Single-use Bioprocessing Systems Market- Opportunities
Rising global demand for biologics and monoclonal antibody therapies to treat various chronic and life-threatening diseases acts as a key opportunity in the global single-use bioprocessing systems market. The development of novel biologics has increased hugely in recent years for indications like cancer, autoimmune disorders, and cardiovascular diseases. This growing pipeline of biologic drugs is fueling a significant demand for large-scale bioprocessing and production capabilities.
Single-use bioprocessing systems help biomanufacturers scale up production volumes efficiently and flexibly to meet this growing commercial demand. Their use across upstream and downstream processing allows for quicker production timelines at a lower cost. This factor is positively influencing the adoption of single-use bioprocessing systems for large-scale commercial production of in-demand biologics and monoclonal antibody therapies.
Global Single-use Bioprocessing Systems Market Segmentation:
The global single-use bioprocessing systems market report is segmented into product type, application, end user, and region.
Based on product type, the market is segmented bioreactors, bags and containers, filtration devices, tubing assemblies and connectors, sensors and probes, and others (accessories & consumables, etc.). Out of which, bioreactors contributes the highest share of the market owing to their increased efficiency and ability to process multiple batches simultaneously. Bioreactors, such as single-use stirred-tank bioreactors and wave bioreactors, allow for greater control over culture parameters like pH, temperature, oxygen levels and nutrition during cell culture processes. Their design also ensures optimum mixing and mass transfer, uniformly distributing nutrients to cells while removing waste. This enhances cell growth and productivity.